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Abstract
Aims Ectopic fat is a recognized contributor to insulin resistance and metabolic dysfunction, while the role of fat deposition 
inside intestinal wall tissue remains understudied. We undertook this study to directly quantify and localize intramural fat 
deposition in duodenal tissue and determine its association with adiposity.
Methods Duodenal tissues were collected from aged (21.2 ± 1.3 years, 19.5 ± 3.1 kg, n = 39) female baboons (Papio sp.). 
Fasted blood was collected for metabolic profiling and abdominal circumference (AC) measurements were taken. Primary 
tissue samples were collected at the major duodenal papilla at necropsy: one full cross section was processed for hematoxy-
lin and eosin staining and evaluated; a second full cross section was processed for direct chemical lipid analysis on which 
percentage duodenal fat content was calculated.
Results Duodenal fat content obtained by direct tissue quantification showed considerable variability (11.95 ± 6.93%) and 
was correlated with AC (r = 0.60, p < 0.001), weight (r = 0.38, p = 0.02), leptin (r = 0.63, p < 0.001), adiponectin (r = − 0.32, 
p < 0.05), and triglyceride (r = 0.41, p = 0.01). The relationship between duodenal fat content and leptin remained after adjust-
ing for body weight and abdominal circumference. Intramural adipocytes were found in duodenal sections from all animals 
and were localized to the submucosa. Consistent with the variation in tissue fat content, the submucosal adipocytes were 
non-uniformly distributed in clusters of varying size. Duodenal adipocytes were larger in obese vs. lean animals (106.9 vs. 
66.7 µm2, p = 0.02).
Conclusions Fat accumulation inside the duodenal wall is strongly associated with adiposity and adiposity related circulat-
ing biomarkers in baboons. Duodenal tissue fat represents a novel and potentially metabolically active site of ectopic fat 
deposition.
Introduction
The ectopic deposition of triglyceride is an important con-
tributor to obesity associated insulin resistance metabolic 
dysfunction [1]. Adverse metabolic effects of excess ectopic 
fat in liver and skeletal muscle are well documented [2, 3]. 
Additional sites of ectopic fat deposition continue to be iden-
tified [4, 5] and evidence suggests that fat accumulation at 
these sites also contributes to metabolic dysfunction [4–6].
Obesity associated ectopic fat deposition in intestinal 
tissues is suggested by several studies [7–9]. Although the 
occurrence of fat inside the large intestine wall is a well-
described computed tomography (CT) finding in inflamma-
tory bowel disorders [10–12]—known as the fat halo sign—
several reports have also described intramural fat deposition 
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in the intestines of individuals with no inflammatory bowel 
disease [7, 8, 13, 14]. Several of these reports described a 
greater frequency of intestine wall fat among higher body 
weight individuals [7, 8]. Moreover, in a recent study, CT 
detected stomach wall fat was more common in individuals 
with BMI greater than 25 kg/m2 and was linked to higher 
visceral fat, hepatic steatosis, and the presence of intramural 
fat in the ileum and colon [9]. Detailed investigations of 
intestinal fat deposition involving direct quantification of 
intramural fat and its associations with adiposity have not 
been undertaken.
We investigated duodenal tissue fat deposition and its 
relationship to adiposity and circulating metabolic biomark-
ers in a large non-human primate model. Our objectives 
were to: (1) directly quantify intramural fat content in the 
duodenum and determine its association with adiposity; and 
(2) identify and the location of and characterize the nature 
of the fat deposited in the duodenum. We found that duo-
denal wall fat exhibited considerable inter-animal variation, 
was strongly associated with adiposity and adiposity related 
biomarkers, and occurred inside variably sized clusters of 
adipocytes that were distributed throughout the submucosal 
region.
Subjects and methods
Non‑human primates
Samples were obtained from 39 female baboons (Papio Sp.) 
housed at the Southwest National Primate Research Center 
(SNPRC), San Antonio, TX. Female baboons were studied 
to avoid the confounding effects of sex differences in adipos-
ity and metabolic disease risk factors [15, 16].
All baboons used were housed in social groups either in 
large 2.4 ha outdoor corrals or in 95 m2, 9 m-high covered 
outdoor cages according to established National Research 
Council guidelines. Animals were fed a commercial monkey 
chow diet (5LE0 solid feed, LabDiet, PMI, St. Louis, MO) 
containing 3.26 kcal/g with 13.8% fat, 67.2% carbohydrate 
(3% sugar), and 19% protein as a percentage of total energy. 
Water was provided ad libitum and the diet was supple-
mented with grains, fruits, and vegetables.
Our study was designed to utilize an ongoing colony 
management protocol to obtain duodenal tissues in animals 
selected to undergo necropsy. All sample collections were 
conducted over a 3 month period between late May and 
late August. Veterinary health assessments on all animals 
used in the study, including blood chemistry and hematol-
ogy profiles, were found to be normal. Electronic health and 
research procedure records were searched to confirm that the 
animals were not subject to any pharmacological or surgical 
interventions over their lifespans. Animals were consuming 
the same low-fat maintenance diet (as described above) for 
at least 2 years prior to necropsy. Gross examinations and 
histological assessments showed that animals included in 
the final analysis were found to be free of major patholo-
gies, including gastric, small intestine, and large intestine 
pathologies, as determined by a Board Certified Veterinary 
Pathologist (E.J.D., M.O.). Study procedures were approved 
by the Institutional Animal Care and Use Committee of the 
Texas Biomedical Research Institute, San Antonio, TX. 
This research was undertaken in compliance with National 
Guidelines and with American Society of Primatologists 
Principles for the Ethical Treatment of Nonhuman Primates.
Body weight and abdominal circumference 
measurements
Animals were sedated with ketamine hydrochloride 
(VEDCO, St. Joseph, MO), at 10 mg/kg and body weight 
was measured three times and averaged to the nearest 0.1 kg 
using a calibrated electronic weighing scale (GSE 665, 
Texas Scales Inc., Cibolo, TX). After euthanasia, with the 
animal supine, abdominal circumference (AC) was measured 
three times and averaged to the nearest centimeter at the 
midpoint between the lowest rib and the iliac crest, using 
a calibrated fixed tension plastic measuring tape (Gulick 2 
Plus, Creative Health Products, Ann Arbor, MI).
Clinical pathology and circulating biomarkers
After a 12 h overnight fast, baboons were anesthetized 
with ketamine hydrochloride (VEDCO, St. Joseph, MO), at 
10 mg/kg and blood samples were collected from the femo-
ral vein and processed for plasma and serum. Fasting serum 
chemistries (including glucose, triglyceride, total choles-
terol, and HDL cholesterol) were analyzed using an ACE 
Clinical Chemistry Analyzer (Alfa Wassermann Diagnostic 
Technologies, LLC, West Caldwell, NJ). Serum insulin and 
C-peptide were measured by automated radioimmunoassay 
(Immulite™1000 Immunoassay System, Siemens Medical 
Solutions Diagnostics, Los Angeles, CA). Fasting plasma 
leptin and adiponectin (26,414 Da form) concentrations were 
analyzed in duplicate using commercially available ELISA 
kits (EMD Millipore, Billerica, MA). Intra-assay CVs for 
leptin and adiponectin were 2.2 and 5.2%, respectively.
Necropsy tissue collection, histology 
and immunocytochemistry
Animals were euthanized using an intravenous injection 
(0.2 mg/kg) of pentobarbital sodium (Fatal-Plus Solution™, 
Vortech Pharmaceuticals, Dearborn, MI) and necropsy 
was initiated with open laparotomy. A full cross section of 
duodenum was systematically collected from each animal 
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at the level of the major duodenal papilla as identified by 
veterinary pathologists (E.J.D., M.O.). All extraneous tis-
sues, including mesenteric adipose tissue, were carefully 
dissected and removed from the duodenal wall. The cleaned 
section was then divided into two additional cross sections. 
The first section was fixed in 10% neutral buffered forma-
lin, processed conventionally, embedded in paraffin, cut at 
5 µM, and stained with hematoxylin and eosin (H&E). Slide 
images were captured using a Nikon DXM1200C camera 
mounted on a Nikon Eclipse 80i microscope (Nikon Instru-
ments Inc., Melville, NY). The remaining full-thickness tis-
sue cross section (~ 2 cm) was placed in a cryovial, imme-
diately frozen in liquid nitrogen, and stored at − 80 °C for 
direct lipid quantification. After completion of duodenal tis-
sue collection, additional gastric, jejunal, and colonic tissues 
were collected and processed for histology assessments as 
described above. Immunocytochemistry for CCK e GLP-1 
was performed as previously described [17].
Quantification of duodenal tissue fat content
Direct chemical analysis of fat content (total lipid) was 
undertaken by SDK Laboratories (Hutchison, KS) using 
the direct ether extraction technique. Analyses were per-
formed on two 5-g cross sections taken from each duode-
nal sample. The technique was performed according to 
the Association of Official Analytical Chemists (AOAC) 
Method 920.39C [18]. In this laboratory, the inter-assay 
CV for two repeat measurements on samples from 12 dif-
ferent animals was found to be 10.5%. The average of the 
measured fat content from each of the two tissue cross 
sections was used to represent duodenal tissue fat content 
(DFAT) was expressed as a percentage of total duodenal 
tissue mass (%DFAT). (Table 1).
Measurement of submucosal adipocyte size
Adipocyte cell sizing was undertaken on duodenal slide 
sections from a subsample of lean (n = 3) and obese (n = 3) 
baboons selected based on AC measurements. Lean and 
obese animals were selected based on AC less than the 
25th percentile and greater than the 75th percentile of 
the sample, respectively. Images for cell sizing from each 
H&E-stained slide were captured using an Olympus Tri-
nocular Microscope (Olympus Corporation of the Ameri-
cas, Center Valley, PA) and BioQuant Osteo II (version 
8.10.20, BioQuant Image Analysis Corporation, Nashville, 
TN). Two-hundred adipocytes per animal were randomly 
selected across the slides to remove any site-specific bias. 
Cell size analysis was undertaken using ImageJ software 
[19] with 64-bit Java 1.8.0_77. Pixels were converted to 
µm by applying the pixel/µm ratio of the microscope using 
the “SCALE” function on ImageJ. The final cell size data 
used for analysis represent the mean of 200 individual adi-
pocytes from each of the baboons (n = 6). The analyst was 
blinded to the obesity status of the animals.
Table 1  Distribution statistics and percentiles of the directly quantified duodenal fat content variable, n = 38
DFAT duodenal tissue fat mass in grams, %DFAT fat mass as a percentage of the total duodenal tissue mass, CI confidence interval
Mean SD SEM Min–max
DFAT (g) 0.60 0.34 0.06 0.07–1.35
%DFAT 11.95 6.93 1.13 1.38–27.05
DFAT percentiles (g) Value 95% CI
10th 0.13 0.07–0.29
25th 0.31 0.13–0.43
50th 0.54 0.39–0.73
75th 0.82 0.69–1.03
90th 1.06 0.92–1.35
%DFAT percentiles Value 95% CI
10th 2.6 1.4–5.7
25th 6.3 2.6–8.7
50th 10.9 7.7–14.5
75th 16.3 13.8–20.7
90th 21.2 18.4–27.1
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Statistical analysis
Distributional characteristics of the newly generated duo-
denal tissue fat content variable (DFAT/%DFAT) were 
analyzed using Shapiro–Wilk and Anderson–Darling tests 
for deviation from the Gaussian normal distribution and a 
two-tailed classical Grubbs test at an alpha level of 0.05 
for outlier identification. %DFAT percentiles were calcu-
lated using the weighted average at Xnp method with nor-
mal distribution-based confidence intervals. Relationships 
among the variables were determined using Pearson cor-
relation and coefficients of determination (R2) from ordi-
nary least squares regression. Mean values comparisons 
were undertaken using two-tailed independent samples t 
tests. Principal component regression analysis was used to 
model the relationship between leptin and the inter-corre-
lated adiposity variables: accounting for multicollinearity 
among the predictor variables [20]. Statistical analysis was 
undertaken using XLSTAT version 19.01.42700 (Addin-
soft, Paris, France) and the R package version 3.4.0 (The R 
Foundation for Statistical Computing, http://www.r-proje 
ct.org).
Results
All animals (21.2 ± 1.3 years, 19.5 ± 3.1 kg) had normal 
renal function and liver enzyme profiles according to age 
(Suppl. Table 1a).
All duodenal tissues were normal based on histological 
assessments by Board Certified Pathologists (EJD, MO). 
Descriptive data for the metabolic variables studied are 
given in Supplemental Table 1b. Significant quantities of fat 
were present in the duodenal tissues of all animals (n = 39) 
and showed considerable variation. One outlier was identi-
fied in the %DFAT data (G = 3.97, p < 0.001, Suppl. Fig-
ures 1A & 1B). After removing the outlier, %DFAT had a 
normal distribution (Suppl. Figures 1c–e), with a mean and 
standard deviation of 11.95 ± 6.93%. Detailed descriptive 
and percentile data for %DFAT (with outlier removed) are 
given in Table 2. %DFAT was significantly correlated with 
both body weight and with AC (Fig. 1). A stronger correla-
tion between %DFAT and AC than between %DFAT and 
body weight was observed. These relationships were present 
regardless of whether the previously detected outlier was 
included (Fig. 1a–c) or excluded (Fig. 1d–f). This outlier 
was excluded from the subsequent analyses.
Fig. 1  Scatter plots of the relationships among percentage duodenal fat content (%DFAT), abdominal circumference, and body weight before 
(a–c, n = 39) and after outlier removal (d–f, n = 38)
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H&E staining revealed a consistent presence of adipo-
cytes in the submucosal layer of the duodenum in all ani-
mals. Clusters of adipocytes of varying size were observed 
to be diffusely deposited across the duodenal submucosa. 
Variation in the duodenal submucosal adipocyte deposi-
tion in four representative animals is shown in Fig. 2. Large 
clusters of adipocytes/adipose tissue deposits (Fig. 2d) were 
observed in several animals. Duodenal submucosal adipo-
cytes from obese animals were 60% larger (106.9 ± 9.2 
vs. 66.7 ± 3.4 µm2, p = 0.02) than those from lean animals 
(Fig. 3), descriptive data for this subset of animals are pro-
vided in Suppl. Table 2. The variation in both adipocyte 
number and adipocyte size was consistent with the varia-
tion in directly quantified duodenal wall fat content. Further 
assessments of gastrointestinal tissues collected from these 
animals during necropsy revealed that adipocytes were dis-
tributed in similar diffuse patterns in the gastric, jejunal, and 
colonic submucosae (Suppl. Figure 3).
To have some indication whether fat deposition in the 
duodenum can influence food intake and body weight, CCK 
and GLP-1 expression were evaluated by immunocytochem-
istry in duodenal sections of lean and obese animals (Suppl. 
Figure 4). While it was notable in these samples the expan-
sion of adipose tissue of the submucosa in obese, there are 
no apparent differences in the number of GLP-1 immuno-
reactive cells between lean and obese animals. However, 
it seems that CCK cells are more numerous in the obese 
animals. A future systematic study in a larger number of 
samples will look to substantiate these possible changes and 
potential pathophysiological implications.
Relationships among %DFAT, AC, body weight, and 
circulating metabolic biomarkers concentrations are shown 
in Fig. 4. %DFAT was significantly correlated with fasting 
leptin (r = 0.63, p < 0.001, Fig. 4a), adiponectin (r = − 0.32, 
p < 0.05, Fig.  4d), and triglyceride (r = 0.41, p = 0.01, 
Fig. 4g). Combined, the correlations suggested that leptin, 
adiponectin, and triglyceride were more strongly related to 
%DFAT than to AC (Fig. 4b, e, h) or body weight (Fig. 4c, 
f, i). %DFAT was not correlated with glucose, insulin, 
C–peptide, total cholesterol, or HDL–cholesterol. A matrix 
showing all correlations is provided in Suppl. Table 3. 
The relationship between %DFAT and leptin was strong 
and was similar in magnitude to the relationship between 
body weight and leptin (Suppl. Fig. 2). A regression model 
accounting for the collinearity among body weight, AC, and 
%DFAT revealed that %DFAT remained strongly associated 
with fasted leptin concentrations after accounting for varia-
tion in body weight and AC (Table 2, Suppl. Table 4).
Discussion
Findings from several studies suggest an association between 
obesity and the presence of intramural fat in the gastroin-
testinal tract. To date, direct investigation of intestinal wall 
fat in relation to adiposity has not been undertaken. Here, 
we present the first evidence to show that intramural fat in 
the duodenum is associated with adiposity, circulating adi-
pokines, and triglyceride concentrations. Our histology find-
ings indicate that duodenal fat is deposited predominantly 
inside adipocytes located in the submucosal tissue layer. 
Combined, our data are consistent with the duodenum as 
a novel and potentially metabolically active site of ectopic 
fat deposition.
The accumulation of triglyceride in tissues such as liver, 
skeletal muscle, vasculature, and pancreas is widely docu-
mented in human and animal models of obesity and, in some 
cases, is strongly linked to metabolic pathophysiology [1–6]. 
To date, a small number of intestinal imaging studies has 
suggested that there is also obesity associated fat deposition 
within the tissues of the gastrointestinal tract. Intramural 
fat accumulation in the colon has been widely reported as 
a distinct ring of low-density tissue on computed tomog-
raphy scans; it is known as the fat halo sign and is a com-
mon finding in Crohn’s disease and associated inflammatory 
bowel conditions [10–12]. Increased numbers of submucosal 
adipocytes are likely to underlie this phenomenon [12, 14]. 
Notably, fat halos have also been reported in the intestines 
of patients with no inflammatory bowel diseases and were 
found to be associated with body weight [7, 8, 13]. Although 
Table 2  Principal component regression analysis, dependent variable 
fasted leptin, n = 38
Dependent variable fasted plasma leptin regressed on %DFAT, body 
weight, and abdominal circumference, n = 38. Adjusted R2 = 0.54, 
root mean square error = 1.03.
PC principal component, %DFAT percentage duodenal fat content, 
AC abdominal circumference
a Results of the principal component model transformed back into the 
original data space to show the model parameters as they correspond 
to the original input variables. The principal component analysis (that 
generated PC1-3) is detailed in Supplemental Table 4
Sum of squares Mean squares F p
Model 49.24 16.41 15.42 < 0.0001
Value SE t p
Principal components model
 Intercept 2.72 0.17 16.22 < 0.0001
 PC1 0.65 0.11 5.71 < 0.0001
 PC2 0.27 0.21 1.30 0.202
 PC3 − 1.27 0.37 − 3.54 0.001
Input variables  modela
Intercept − 1.27 18.34 − 0.06 0.945
Weight 0.29 0.08 3.69 0.001
AC − 0.07 0.03 − 2.02 0.052
%DFAT 0.14 0.03 4.52 < 0.0001
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a recent histological evaluation of autopsy samples did not 
find a correlation between submucosal thickness—used as a 
surrogate for submucosal adipose deposition—and BMI in 
male patients [14], it is possible that the indirect submucosal 
thickness measurements did not sufficiently capture varia-
tion in intestine wall fat, particularly given the non-uniform 
distribution of submucosal adipocytes. It is also possible 
that intramural fat in the distal intestine is not as strongly 
associated with obesity as that of the proximal intestine. 
In support of this argument, results from a large study by 
Gervaise et al. [9] showed computed tomography evidence 
for stomach wall fat accumulation in a subset of individuals 
with higher BMIs, greater visceral fat, and no known gastro-
intestinal disease [8]. Fat deposition in relation to adiposity 
in the proximal small intestine wall has not been reported.
Our data show that duodenal tissue fat content, quanti-
fied by direct chemical analysis, is strongly associated with 
body weight and central adiposity in the highly clinically 
relevant baboon model [16, 21–24]. Baboons show consid-
erable variation in body fat [21] and a form of diabetes, 
consistent with human type 2 diabetes occurs in baboons 
[16]. Furthermore, fat gain and dysmetabolism can be 
Fig. 2  Representative hematoxylin and eosin-stained duodenal wall 
sections from four baboons. Panels show the presence of adipocytes 
in the submucosa. Panels represent the variation seen in duodenal 
submucosal adipocyte accumulation in the sample studied: from 
small numbers of adipocytes (Panel A) to large clusters resulting in 
expansion of the submucosa (Panel D)
Fig. 3  Box-plots of adipocyte cell size variation in lean (n = 3) and 
obese (n = 3) baboons. Bars represent median and 25–75th percen-
tiles. The representative images to show the adipocyte size are also 
provided
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induced by diet in baboons [23]. Importantly, aged baboons 
(21 years) like those used in this study, reflects human older 
age (55–65 years), are insulin-resistant and have many of 
the molecular and cellular features of human skeletal muscle 
and adipose tissue insulin resistance [16, 25]. In addition, 
pancreatic islet pathology in diabetic baboons is similar 
to that of humans [22, 26, 27]. The pragmatic advantages 
offered by working with a large, long-lived, and tractable 
non-human primate, make the baboon a highly important 
and valid model for the study of obesity and related diseases. 
The animals used in this study are all female because they 
were present in large excess of males in the colony and were 
the focus of the management efforts. Although, the phenom-
enon of submucosal lipid deposits has also been found by 
our pathologists in male animals, we were unable to include 
enough males to have an appropriately balanced sample and 
therefore we chose to focus primarily on females.
Our findings advance those of previous imaging stud-
ies and demonstrate a robust association between adipos-
ity and %DFAT. We show that duodenal fat content is a 
normally distributed variable with considerable inter-animal 
variability. This variation was consistent with histological 
observations of high variability in submucosal adipocyte 
accumulation in duodenal sections from the same animals. 
Our other histology findings suggest that submucosal adi-
pocyte clusters of varying size are present throughout the 
length of the gastrointestinal tract. Intramural adipose in the 
submucosa of the gastrointestinal tract may represent a rela-
tively large and underappreciated ectopic fat depot.
We found robust relationships between %DFAT and 
obesity associated circulating biomarkers. Although we 
did not see any relationships between %DFAT, glucose, 
and insulin, we found that fasting plasma leptin and adi-
ponectin, and serum triglyceride concentrations were 
significantly correlated with duodenal tissue fat content. 
Taken together, the correlations suggest that circulating 
leptin, adiponectin, and triglyceride concentrations were 
more strongly related to %DFAT than to AC. Although we 
were limited to the use of AC as a measure of whole-body 
adiposity, we have previously shown that AC is a robust 
predictor of dual-energy X-ray absorptiometry measured 
body fat in baboons [16, 28] as both male and female 
Fig. 4  Scatter plots of the interrelationships among leptin, adiponectin, and triglyceride and percentage duodenal fat content (%DFAT), abdomi-
nal circumference, and body weight
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baboons distribute excess body fat in the abdominal region 
[15]. However, we have previously shown that whole-body 
fat deposition negatively affects insulin sensitivity deter-
mined by the gold standard methodology, the euglycemic 
clamp as well as indirect measures of insulin sensitiv-
ity such as Homa-IR and insulin levels [16, 28]. Thus it 
is likely that also in this study, DFAT in obese animals 
might also contribute to whole-body insulin resistance. 
Moreover, the negative association between adiponectin 
and DFAT suggests that it may influence insulin sensitiv-
ity, at least indirectly.
The relationship between %DFAT and leptin was par-
ticularly strong. After accounting for the interrelationships 
among body weight, AC, and %DFAT in a regression model, 
%DFAT remained a strong predictor of fasted leptin concen-
trations. Stomach epithelial cells are known to produce lep-
tin [29] and leptin itself exerts multiple actions on intestinal 
cells [30]. The strength of the relationship between duodenal 
fat content and circulating leptin may indicate involvement 
of submucosal adipose in regulation of circulating leptin 
concentrations or conversely, that circulating leptin/leptin 
resistance influences submucosal fat accumulation. None-
theless, in the absence of a more direct measure of body 
composition, the association between leptin and %DFAT 
may be best understood as reflecting a strong relationship 
between %DFAT and whole-body fat stores. It will be nec-
essary to further explore and unravel these relationships in 
future studies.
Our findings are consistent with duodenal fat accumu-
lation occurring primarily inside submucosal adipocytes 
that expand in both number and size with increased duo-
denal fat content. It is known that ectopic fat deposition in 
the pancreas also occurs inside adipocytes [31, 32]. Small 
intestine submucosal adipocytes are frequently described in 
histology texts [33] but have not received much attention 
and their origin is unknown. The presence of large clusters 
of adipocytes resulted in duodenal submucosal expansion, 
as previously shown in human ileal and colonic submucosae 
[14]. We also found that submucosal adipocytes from obese 
baboons were significantly larger than those of their lean 
counterparts, indicating that, as with other adipose depots 
[34], submucosal adipose tissue expansion is likely to result 
from both an increase in cell size and cell number. The role 
of submucosal adipocytes in normal physiology is unknown. 
In addition to blood and lymphatic vessels, the submucosa 
contains Meissner’s plexus, a branch of the enteric nerv-
ous system, which innervates the cells of the mucosa and 
the vasculature cells of the submucosa. Hanani et al. have 
reported that neurons of Meissner’s plexus directly innervate 
submucosal adipocytes in the human colon [35]. These data 
suggest the intriguing possibility of a functional relation-
ship between submucosal nerves and nearby adipocytes. 
Whether submucosal adipocytes engage in cross-talk with 
other intestinal cell types and what effect, if any, their expan-
sion has on intestinal cell function will require investigation.
The data presented herein provide the first evidence for 
the presence of adiposity associated ectopic fat deposition 
in the duodenal tissue and provide a foundation for further 
investigation in baboons, which are extensively charac-
terized non-human primate model for obesity, metabolic 
syndrome and type 2 diabetes mellitus. Further studies are 
needed to: (1) replicate the associations between adipos-
ity and duodenal fat quantified using non-invasive intestinal 
imaging in humans; (2) quantify the deposition of intramu-
ral fat throughout the gastrointestinal tract and determine 
its association with adiposity; and (3) determine the role 
submucosal adipocytes and the effects of their increased 
accumulation on intestinal function. In conclusion, duode-
nal tissue fat represents a novel and a potentially important 
site of ectopic fat deposition. Duodenal fat, in addition to 
intramural adipose throughout the submucosa of the gastro-
intestinal tract, warrants further investigation.
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